Pearson-Stuttard J, Cheng YJ, Bennett J et al (2022) Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records
If so, Melanotan 1 is your instrument
Scientific Context and References The synergistic effect of combining GHRH and GHRP has been thoroughly documented in dozens of clinical and preclinical studies available in the international medical database PubMed
Hirose S, Mitsudome A, Yasumoto S, et al
The evidence for GLP-1 medications in treating NASH (the more severe form of fatty liver disease) is particularly impressive: Liraglutide achieved histological resolution of steatohepatitis in 39% of cases after 48 weeks, compared to just 9% in placebo groups 20 Patients taking liraglutide had 4.5 times higher likelihood of NASH resolution than those on placebo 20 Semaglutide demonstrated NASH resolution in 59% of participants versus 17% in placebo groups 21 We offer FibroScan technology to measure liver stiffness and fat content, helping us monitor your progress while on GLP-1 therapy
Sulforaphane (Broccoli Sprouts) The Detox Switch Activation Supports: liver genes, phase II clearance enzymes, kidney oxidation defense Specializes In: hydrocarbon residues, flame retardants, PAHs, diesel particulates Why it matters: it turns ON the genes that detoxify modern pollutants Sulforaphane activates Nrf2 pathways that tell detox organs to upregulate defense enzymes